Clinical Trial Update: Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two commercial formulations of botulinum toxin type A for the treatment of spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• Botulinum toxin type A (commercial formulation 1) (botulinum toxin type A)
• Botulinum toxin type A (commercial formulation 2) (botulinum toxin type A)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Spasticity | Phase 3 | Status: COMPLETED